For the quarter ending 2025-09-30, DERM made $17,631,000 in revenue. -$2,315,000 in net income. Net profit margin of -13.13%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenue | 17,631,000 | 15,009,000 | 13,139,000 | 13,325,000 |
| Cost of goods sold - (excluding amortization of acquired intangible assets) | 5,755,000 | 4,939,000 | 4,790,000 | 4,526,500 |
| Amortization of acquired intangible assets | 1,064,000 | 1,064,000 | 1,065,000 | 856,000 |
| Research and development | 287,000 | - | 39,000 | 4,051,000 |
| Loss recovery | - | - | - | 1,138,250 |
| Selling, general and administrative | 12,054,000 | 11,882,000 | 10,569,000 | 9,240,000 |
| Total operating expenses | 19,160,000 | 17,885,000 | 16,463,000 | 17,253,000 |
| Loss from operations | -1,529,000 | -2,876,000 | -3,324,000 | -3,928,000 |
| Interest income | 154,000 | 138,000 | 149,000 | 204,000 |
| Interest expense | 937,000 | 937,000 | 891,000 | 689,500 |
| Gain on extinguishment of debt | - | - | - | 0 |
| Foreign exchange transaction losses | -3,000 | -61,000 | -7,000 | -16,500 |
| Total other expense (income) | -786,000 | -860,000 | -749,000 | -502,000 |
| Loss before income taxes | -2,315,000 | -3,736,000 | -4,073,000 | -4,430,000 |
| Income tax expense | - | 60,000 | - | 15,250 |
| Net loss | -2,315,000 | -3,796,000 | -4,073,000 | -4,460,500 |
| Earnings per share, basic | -0.09 | -0.16 | -0.18 | -0.215 |
| Earnings per share, diluted | -0.09 | -0.16 | -0.18 | -0.215 |
| Weighted average number of shares outstanding, basic | 24,959,114 | 23,290,806 | 22,611,040 | -10,050,126 |
| Weighted average number of shares outstanding, diluted | 24,959,114 | 23,290,806 | 22,611,040 | -10,050,126 |
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)